baber/WOPTO huggingface dataset:
Patent NZ-514851-A (NZ)
Title: Tamper evident reclosable plastic bag
Inventor: BUCKMAN THOMAS W
IPC: B65D33/25
Filed: 2001-10-16
Abstract: A reclosable package having a front wall and a rear wall joined at the bottom and sides and an open top containing a zipper.  The zipper has a first profile and a second profile each including interlocking members adapted to mate with each other.  One profile has a flange secured to its associated wall at a location proximal a top end of that wall.  The second profile has a flange portion secured to the other wall proximal a top end of that wall and to the first wall at a location below the location at which the first flange is secured to the first wall.  A line of weakness extends along the second flange portion parallel to the profile interlocking member and between the two securing points.
Patent NZ-516926-A (NZ)
Title: Harness safety alarm
Inventor: SHERMAN ROBYN ANN
IPC: B60R22/12
Filed: 2000-07-27
Abstract: A harness safety alarm for providing a warning in the event that a seat belt is uncoupled comprises a proximity sensor (19) connected by straps (20, 21) to a seat belt buckle (13). A detectable means (22), such as a magnet, is attached by strap (23) to the tongue (16) of the seat belt. A warning unit (30), which is mounted remotely from the proximity sensor (19), provides an audible and visual warning if the seat belt is uncoupled. In particular, if the seat belt is uncoupled, the sensing means (19) sends a radio frequency signal to the warning unit (30) to thereby activate the audible and visual warning.
Patent NZ-522276-A (NZ)
Title: Serological assay for neospora caninum comprising contacting a serum sample with a toxoplasma gondii protein
Inventor: BRAKE DAVID ALAN
IPC: C12Q1/68
Filed: 2002-10-30
Abstract: A method for distinguishing a non-human animal naturally seropositive for N. caninum from a non-human animal vaccinated with a Neospora vaccine comprises obtaining a serum sample from the animal and contacting the serum with a Toxoplasma gondii protein and examining the serum for the presence of an antibody that binds to the protein wherein detection of bound antibody indicates a naturally seropositive animal. Preferably the protein is BAG-1 or BAG-5. Also described is a method for diagnosing a non-human animal suspected of having been infected with N.caninum and a method for detecting antibodies to Neospora caninum.
Patent NZ-523426-A (NZ)
Title: Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities
Inventor: VON FALKENHAUSEN CHRISTIAN
IPC: A61K9/70
Filed: 2001-06-22
Abstract: A dosage form which is, in particular, sheet-like and rapidly disintegrating or soluble in an aqueous environment for rapid release of active ingredients in the oral cavity, in body orifices or in body cavities, where the dosage form comprises a matrix which comprises one or more water-soluble polymers as base substances, and comprises at least one active ingredient, is characterized in that the dosage form is provided with spaces or cavities which are present in the polymeric matrix and whoe contents differ in terms of the state of aggregation from the matrix.
Patent NZ-524052-A (NZ)
Title: Extruded vinyl aromatic foam with 1,1,1,2-tetrafluoroethane (134A) and alcohol as blowing agent and method of preparation thereof
Inventor: MILLER LARRY M
IPC: C08J9/14
Filed: 2001-05-16
Abstract: Methods for preparing extruded foam products and more particularly a method for producing such products with a blowing agent containing 134a (1,1,1,2 tetrafluoroethane) and an alcohol are disclosed, wherein the particular method comprises: a) heating to a first temperature a resin mixture comprising an alkenyl aromatic polymer and optional additives thereby producing a plastified resin mixture, b) thoroughly mixing with the resin mixture a blowing agent consisting of 134a and an alcohol under a first pressure and under conditions to prevent foaming thereby producing a foamable gel, c) cooling the foamable gel to a second temperature and extruding the formable gel into a second pressure less than the first pressure thereby causing the foaming of the gel and formation of an extruded foam product.
Patent NZ-528209-A (NZ)
Title: The citrate salt of 5, 8, 14-triazatetracyclo (10.3.1.02,11.04.9)-hexadeca-2.(11),3,5,7,9-pentaene
Inventor: JOHNSON PHILLIP JAMES
IPC: A61P25/16
Filed: 2002-04-26
Abstract: The citrate salt of 5, 8, 14-triazatetracyclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene, and pharmaceutical compositions thereof are described. The application is also directed to the various forms of the citrate salt, particularly its hydrate and its anhydrous/nearly anhydrous polymorph. The aforementioned compound is described as being useful in the treatment of inflammatory bowel disease, ulcerative colitis, Crohn's disease, and the like. It is also described as being used in medicaments for the treatment of many other disorders including trauma, AIDS and Tourette's syndrome.
Patent NZ-531722-A (NZ)
Title: Endogenous and non-endogenous versions of human G protein-coupled receptors
Inventor: CHEN RUOPING
IPC: C12N15/09
Filed: 2000-11-16
Abstract: A polynucleotide encodes a G protein-coupled receptor having the sequence shown as SEQ ID NO:38. Also described are vectors, host cells, GPCR fusion proteins, pharmaceutical compositions and methods of identifying modulators of G protein-coupled receptors. Modulators of the receptor may be useful for treating pancreatic endocrine disorders and pancreatic endocrine disorders, diabetes and pancreatic insufficiency.
Patent NZ-533660-A (NZ)
Title: Slit-type swabable valve
Inventor: MILLER PAVEL T
IPC: F16K15/18
Filed: 2002-12-27
Abstract: A valve, which includes a stem having a slit at an end thereof is disclosed. The valve stem is located in a valve body and is deformable. When a tip of an instrument is engaged with a slit in the stem, the stem shifts in the body, top portion folds inward, the slit seals against the instrument and allows liquid to flow through the stem, to or from the instrument. All components have circular cross sectional geometry.
Patent NZ-534240-A (NZ)
Title: Inkjet recording ink for sublimation transfer and method of dyeing
Inventor: MAEKAWA SHUNJI
IPC: C09D11/38
Filed: 2003-08-14
Abstract: An ink for sublimation transfer ink jet recording includes water, at least one sugar alcohol containing not less than four OH groups, a sublimation dye, and a dispersant is disclosed. The ink is printed on a sheet medium by ink jet printing, and then the sheet medium is heated to sublimate and transfer the sublimation dye onto the object to be dyed. The ink for ink jet recording and the sublimation transfer dyeing method using the ink not only can maintain performances such as storage stability and high-quality recording images, but can also reduce environmental pollution, effectively prevent nozzle clogging, and exhibits good dispersion stability. Also disclosed is a method of sublimation transfer dyeing with the use of the inkjet recording ink
Patent NZ-535452-A (NZ)
Title: Tropane derivatives as CCR5 modulators
Inventor: BASFORD PATRICIA ANN
IPC: C07D451/04
Filed: 2003-03-31
Abstract: Tropane derivative compounds of formula (I) are disclosed, wherein, X, Y, R1, R2 and R3 are as defined in the specification. These tropane derivative compounds are modulators, especially antagonists, of the activity of chemokine CCR5 receptors, and are suitable for use in the treatment of various inflammatory diseases and conditions, and in the treatment of infection by HIV and genetically related retroviruses.
Patent NZ-535681-A (NZ)
Title: Tilt-up concrete wall panel form and method of fabricating same
Inventor: DELOACH W MICHAEL
IPC: E04C2/38
Filed: 2002-12-13
Abstract: A light-weight, portable, self-contained concrete form (11) for fabricating tilt-up concrete walls including a frame made up from metal frame members (12-16) joined at their ends and having a channel shape with the channels facing inwardly. A reinforcing mat (17) including an array of crisscrossed re-bars (18) disposed within the frame (12-16) and held in place by brackets (21) positioned and welded at the ends thereof. The frame may be shipped to the job-site, laid on a casting surface, and filled with concrete. When the concrete cures, the resulting concrete wall, form (11) and all, is tilted-up into place with a crane and attached to form a section of a concrete wall.
Patent NZ-537292-A (NZ)
Title: Therapeutic piperazine derivatives useful for treating pain
Inventor: KYLE DONALD J
IPC: A61P25/14
Filed: 2003-06-27
Abstract: Disclosed are cyanoiminopiperazine compounds of formula (I) wherein A, R1, R2, R3 and R6 are disclosed in the specification. The disclosed compounds are useful in the treatment of pain, urinary incontinence, ulcers, inflammatory bowel disease, irritable-bowel syndrome, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia or depression.
Patent NZ-537698-A (NZ)
Title: A method for preparing medicaments containing vardenafil hydrochloride trihydrate
Inventor: SERNO PETER
IPC: A61K9/20
Filed: 2003-07-03
Abstract: A method for producing medicaments that contain vardenafil hydrochloride, essentially as trihydrate in solid form is disclosed, wherein (a) vardenafil hydrochloride with any water content is employed for producing the medicament; (b) the vardenafil hydrochloride is converted substantially into trihydrate form at an intermediate processing step or in the final product by contacting the vardenafil hydrochloride with moistened gas. These medicaments are suitable for treating erectile dysfunction.
Patent NZ-543808-A (NZ)
Title: System and method for providing preferred country biasing of search results
Inventor: GUPTA VINEET
IPC: G06F17/30
Filed: 2004-06-16
Abstract: A system (10) and method for ordering search results (37), implemented within a computing device, is disclosed. The system (10) comprises: (a) a country selector (49) that dynamically determines at least one preferred country applicable to the search results generated responsive to a search query (36) executed on information (47) in a data repository and provided from a plurality of search result countries (39), where the at least one preferred country (39) is determined based on characteristics of the search query (36) or the search results (37); (b) a search result orderer (34) determines an order for presenting at least one of the search results (37) among other ones of the search results (37) based on whether the at least one of the search results (37) is from the at least one preferred country (39); and (c) a presenter (35) that presenting the search results (37) in the determined order.
Patent NZ-544178-A (NZ)
Title: Novel aminobenzophenone compounds
Inventor: OTTOSEN ERIK RYTTER
IPC: C07C233/43
Filed: 2004-07-09
Abstract: Disclosed is a compound of general formula I wherein R4 is fluoro and the rest of the substituents are disclosed within the specification. Also disclosed is the use of the above compound in the manufacture of a medicament for the prophylaxis, treatment or amelioration of inflammatory diseases or conditions, or ophthalmic diseases or conditions or for the treatment or amelioration of cancer.
Patent NZ-544817-A (NZ)
Title: Multilayer bi-axially oriented high-modulus thermoplastic film
Inventor: FORLONI ROBERTO
IPC: B32B27/30
Filed: 2004-07-21
Abstract: The disclosure relates to a multi-layered, high modulus, bi-axially oriented thermoplastic film, heat-shrinkable or non heat-shrinkable, comprising a first outer layer comprising a polyester or a copolyester, a second outer layer comprising an ethylene or propylene homo- or co-polymer, a core layer comprising an ethylene-vinyl alcohol copolymer, and no core polyamide or polyester layers, wherein the film has a modulus (evaluated according to ASTM D882) higher than 6,000 kg/cm2 in at least one direction. The film is prepared by orienting biaxially a flat extruded tape by means of a tenter frame, preferably simultaneously. The film is particularly useful, in the non heat-shrinkable version, for food and non food packaging applications.
Patent NZ-546783-A (NZ)
Title: Salts and polymorphs of a potent antidiabetic compound
Inventor: KORUK HENRY T
IPC: C07D215/20
Filed: 2004-10-04
Abstract: Salts and polymorphs of a benzenesulfonamide derivative compound useful in the treatment of inflammatory and metabolic conditions and diseases are disclosed herein. In particular, the disclosure provides salts and polymorphs of a compound ( such as 2,4-dichloro-N-[3,5-dichloro-4-(quinolin-3-yloxy)-phenyl]-benzenesulfonamide benzenesulfonate salt; 2,4-dichloro-N-[3,5-dichloro-4-(quinolin-3-yloxy)-phenyl]-benzenesulfonamide hydrochloride salt; and 2,4-dichloro-N-[3,5-dichloro-4-(quinolin-3-yloxy)-phenyl]-benzenesulfonamide p-toluenesulfonate salt) which modulate the expression and/or function of a peroxisome proliferator-activated receptor. These salts and polymorphs are useful for the treatment or prevention of conditions and disorders associated with energy homeostasis such as type II diabetes, lipid metabolism, adipocyte differentiation and inflammation
Patent NZ-547164-A (NZ)
Title: Derivatives of n-[phenyl(piperidine-2-yl)methyl]benzamide, preparation and therapeutic use thereof
Inventor: DARGAZANLI GIHAD
IPC: A61P25/30
Filed: 2004-10-15
Abstract: Disclosed are N-[Phenyl(2-piperidinyl)methyl]benzamide derivatives, corresponding to the general formula (I) The disclosure also relates to the processes of preparation and relates to a therapeutic agent for treating behavioural disorders associated with dementia, psychoses, various forms of anxiety, panic attacks, phobias, obsessive compulsive disorders, various forms of depression, disorders caused by alcohol abuse or weaning from alcohol, sexual behaviour disorders, eating disorders, migraine, contracture, pain, Parkinson's disease and Parkinson-like symptoms, epilepsy, mixed forms and other epileptic syndromes in addition to another antiepileptic treatment, or in monotherapy, and sleep apnea, and for neuroprotection.
Patent NZ-547861-A (NZ)
Title: Nestable tray, blank, corresponding packaging and machine for forming one such tray
Inventor: DURFORT GILLES
IPC: B31B50/30
Filed: 2004-11-25
Abstract: A tray (1) which is made from a sheet of cardboard comprising four lateral walls (2, 3, 4, 5) and a base (6). Two opposing lateral walls are each equipped with a panel (9) which is provided with a longitudinal flap (11) that is intended to form a fold which extends over part of the height of the wall, the cardboard basis weight being less than or equal to 350 g/m2. Also disclosed is a blank, a packaging and a machine used to form one such tray.
Patent NZ-548218-A (NZ)
Title: Antimicrobial composition comprising a casein peptide and a divalent cation useful for treating dental caries
Inventor: REYNOLDS ERIC
IPC: A01N63/50
Filed: 2004-12-15
Abstract: The present disclosure relates to an antimicrobial composition comprising a peptide which can be obtained from the milk protein casein or chemically synthesised or produced by recombinant DNA technology and a divalent cation such as Ca2+ or Zn2+. Further disclosed are uses of the composition in the manufacture of a medicament for treating dental caries, periodontal disease, and inhibiting the accumulation of biofilm.
Patent NZ-550894-A (NZ)
Title: Solid dosage form of wetted heparin
Inventor: MAJURU SHINGAI
IPC: A61K31/166
Filed: 2005-05-06
Abstract: Disclosed is a solid pharmaceutical composition comprising: (a) a delivery agent of formula (I) wherein; R1, R2, R3 and R4 are independently hydrogen, hydroxy, -NR6R7, halogen, alkyl, or alkoxy; R5 is a substituted or unsubstituted alkylene, a substituted or unsubstituted alkenylene, a substituted or unsubstituted alkyl(arylene), or a substituted or unsubstituted aryl(alkylene); and R6 and R7 are independently hydrogen, oxygen, or alkyl; and (b) wetted heparin. Also disclosed is the use of an anti-thrombosis effective amount of the solid pharmaceutical composition as defined above for the manufacture of a medicament for treating or preventing thrombosis in an animal. Of particular importance are the compositions where the delivery agent is monosodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC).
Patent NZ-552206-A (NZ)
Title: Puller for use in animal carcass boning or cutting constrained for substantially downwards movement
Inventor: SEATON MARK HAMISH
Filed: 2006-12-20
Abstract: An apparatus is disclosed for pulling a section of an animal carcass from the carcass wherein the carcass is held using means for holding. The apparatus includes means for anchoring to the section of the carcass, and means for forcibly separating the means for anchoring from the means for holding, preferably in a substantially vertical downwards direction, and thereby remove the section from the carcass. According to preferred embodiments, the means for anchoring may be a hook or a gripper which clamps to the section of the carcass. A system including the apparatus and a corresponding method are also provided.
Patent NZ-562593-A (NZ)
Title: Ligno cellulosic materials and the products made therefrom, using an oxidizing agent with a transition metal catalyst
Inventor: TAN ZHENG
IPC: A61F13/15
Filed: 2006-05-02
Abstract: Disclosed is a process of preparing fluff pulp exhibiting odour (odor) control properties, comprising treating a lignocellulosic material with from 0.1 to 10wt% based upon the weight of the dried lignocellusic material of an oxidizing agent, selected from hydrogen peroxide, hypochlorite, hypochlorous acid and any combination thereof, in the presence of from 0.01 to 0.5wt% of a transition metal catalyst based upon the weight of the dried lignocellusic material at a pH of from 1 to 9 from a time of from 5 minutes to 20 hours to form a treated lignocellulosic material having a viscosity equal to or less than 17 cp and having reducing functional groups selected from the group consisting of aldehyde functional group, hemiacetal functional groups or a combination thereof at the C6 and C1 positions but predominating at the C1 position, wherein the amount of said functional groups at the C1 position is greater than 75%. Also disclosed is the use of the above fluff pulp to prepare personal hygiene articles.
Patent NZ-562707-A (NZ)
Title: A method of modulating endothelial cell activity
Inventor: XIAOCHUN LI
IPC: A61P29/00
Filed: 2003-09-05
Abstract: Disclosed is a method of modulating endothelial cell permeability in vitro, said method comprising modulating the functional activity of protein kinase Czeta wherein up regulating protein kinase Czeta activity up-regulates said cellular permeability and down-regulating protein kinase Czeta activity down-regulates said cellular permeability. (62) Divided Out of 538662
Patent NZ-566420-A (NZ)
Title: Script markup
Inventor: KOTHARI NIKHIL
IPC: G06F3/14
Filed: 2006-08-29
Abstract: A method which facilitates designing the markup for an electronic document which is stored as a markup document in a database associated with a server computing system, and which is later retrieved for viewing and design of the markup document at a browser of a client computing system is disclosed. The method facilitates the design by separating script markup language that defines interactive behaviour and application logic associated with the electronic document from general markup language of the electronic document that defines content and presentation of the electronic document. The method comprises retrieving from a database associated with a server computing system an electronic document stored in the form of a markup document, for display at a browser of a client computing system and presenting the retrieved document for display at the browser of the client computing system with the separate general and script markup portions. The retrieved electronic document has a markup language that defines in a first part of the retrieved electronic document a general markup portion comprised of one or more general markup elements that define formatting of the content and/or the overall appearance of the electronic document when displayed on a Web page. The retrieved electronic document has a markup language that defines in a second part of the same retrieved electronic document a script markup portion comprised of one or more script markup elements that define interactive behaviour and application logic associated with the electronic document when displayed as a Web page. The script markup elements are comprised of one or more reference elements that reference script files that are used to provide implementation details for the interactive behaviour to be implemented by the retrieved electronic document when displayed as a Web page, and component elements comprised of one or more script object definitions used to define behaviour of one or more of the general markup elements included in the general markup portion of the retrieved electronic document, at least one such script object definition being associated with an event, the occurrence of which initiates a corresponding event handler that includes one or more specific actions to be performed on the at least one such script object. One or more of the script markup elements of the script markup portion reference at least one general markup element contained in the general markup portion of the retrieved electronic document, but script elements of the script markup portion are not referenced by any of the general markup elements of the general markup portion of the retrieved electronic document so that the script portion of the retrieved document is kept separate from the general markup portion when presented for viewing and design on a browser of a client computing system.
Patent NZ-570598-A (NZ)
Title: Methods for preventing gluconoylation of proteins in E. coli by inserting a PGL gene sequence
Inventor: GARDNER ALAN R
IPC: C12N1/21
Filed: 2004-03-04
Abstract: Disclosed is a method for preventing gluconoylation of a polypeptide expressed in E. coli, the method comprising introducing into said E. coli recombinant DNA comprising the sequence set forth in SEQ lD NO: 7 (6-phosphoglucono-lactonase) (62) Divided Out of 541927
Patent NZ-572314-A (NZ)
Title: Microcapsules with acetylene carbamide-polyurea polymers and formulations thereof for controlled release
Inventor: CASANA GINER VICTOR
IPC: C08G18/28
Filed: 2007-03-29
Abstract: Disclosed are microcapsules enclosing a material with a solubility in water lower than 750 mg/L at 20 degrees celecius or clomazone, wherein the wall of the microcapsule is formed by means of an interfacial polymerization reaction of the following wall forming materials: (a) aliphatic isocyanate(s), and (b) aromatic isocyanate(s) and (c) compound(s) of formula (I) -acetylene carbamide derivatives - in monomeric and /or oligomeric and/or polymeric form. Also disclosed is the process for preparing the microcapsules and the use of the microcapsules in agricultural formulations.
Patent NZ-572892-A (NZ)
Title: Prion protein ligands with the sequence YVHEA
Inventor: HAMMOND DAVID J
IPC: G01N33/68
Filed: 2003-12-03
Abstract: Disclosed is a prion binding ligand, wherein the ligand is a peptide having an amino acid sequence of SEQ ID NO:63. Also disclosed is a method for detecting a prion with said ligand and compositions thereof. (62) Divided Out of 560410